The quest for better health outcomes

whitePaper | August 11, 2022

The global healthcare industry is facing a seemingly insurmountable number of challenges from aging populations and staff shortages to rising costs that are placing enormous pressure on institutions, doctors, workers, patients and communities.

whitePaper | January 2, 2023

a buying guide to help you choose a healthcare-contextualized CRMsolution that connects consumer experiences and clinical care journeys tohelp you find, guide, and keep patients for life

whitePaper | March 2, 2020

In the decade since the HITECH Act was passed, first-generation electronic health record systems provided a foundation for innovations such as electronic prescribing, clinical decision support and predictive analytics. While usability and productivity issues with EHRs have been well documented, there are significant untapped opportunities to optimize the EHR and health IT. In this whitepaper, PatientKeeper outlines a vision for the future of health IT through the next decade, which includes New data-driven approaches that leverage the clinical information being captured by the EHR to improve patient outcomes and reduce physician burnout, Optimized communication between physicians, nurses and ancillary staff to produce better patient outcomes as efficiencies improve, Better interoperability to improve care coordination and inspire opportunities for ideas like telemedicine to alleviate physician shortages

whitePaper | December 3, 2022

In the past three decades, cloud computing as we now know it has undergone many changes. Long gone are the days where large corporations had a single off-site server parsing data. Today, businesses of all sizes are embracing the cloud for storage to services and beyond.

whitePaper | March 11, 2022

Following the emergence of COVID-19 and significant foundational investment in digital health infrastructure, Australia’s health system, like all health systems globally, is rapidly building momentum towards a digital future.

whitePaper | January 27, 2023

Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.